Global /France /Healthcare /Diagnostics & Research /ALKLH
chevron_leftBack

Klea Holding S.A.

ALKLH
EPA: ALKLH Delayed
0.1794EUR -0.4%
0.2041 USD
As of 24 April 2025, Klea Holding S.A. has a market cap of $63.02M USD, ranking #23362 globally and #332 in France. It ranks #2348 in the Healthcare sector, and #113 in the Diagnostics & Research industry.
Global Rank
23362
Country Rank
332
Sector Rank
2348
Industry Rank
113
Key Stats
Market Cap
$63.02MUSD
55.38M EUR
Enterprise Value
$67.04MUSD
58.91M EUR
Revenue (TTM)
$17.28MUSD
15.18M EUR
EBITDA (TTM)
$2.43MUSD
2.14M EUR
Net Income (TTM)
$1.86MUSD
1.64M EUR
EBITDA Margin
14%
Profit Margin
11%
PE Ratio
38.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Clement Pacaud open_in_new
Employees
94
Founded
2007
Website
kleaholding.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.4% 0.2% -11% -9.8% -15% -11%
Upcoming Earnings
Earnings Date
Mon, Apr 28

Markets

Exchange Ticker Price
Euronext Paris
MIC: XPAR
PRIMARY
ALKLH
Klea Holding
ISIN: FR0013481835
Shares Out.:
307.326M1 Shares Float: 159.565M2
TV:
SA:
YF:
GF:
BA:
MS:
0.1794 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Klea Holding S.A.

Klea Holding SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions, including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. The company was formerly known as Visiomed Group SA and and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 2007 and is headquartered in Paris, France.

Similar Companies

Industry: Diagnostics & Research (France)
Name
Market Cap diff.
bioMérieux S.A.
BIM
$15.23B
13.39B EUR
24K%
Lumibird S.A.
LBIRD
$226.41M
198.96M EUR
259%
Predilife S.A.
ALPRE
$15.5M
13.62M EUR
-75%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
258K%
Danaher Corp.
DHR
$140.49B
223K%
Lonza Group AG
LONN
$48.07B
39.7B CHF
76K%
IDEXX Laboratories, Inc.
IDXX
$34.57B
55K%
Agilent Technologies, Inc.
A
$29.94B
47K%